---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008395"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:57:33.396840+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical issues up to 45,000 Series A convertible preferred shares at $0.01 for reverse split vote

## Summary
- 45,000 shares of Series A preferred issued at $0.01/share; convertible into common at $0.01/share after stockholder approval of reverse split.
- Holders get 2,000 votes per share solely on the reverse stock split proposal; agree to vote in same proportion as common holders.
- Redemption right arises after authorized share increase approval or 90 days from closing, until 120 days after closing.
- Net proceeds used for general corporate purposes if shares not redeemed or converted; total potential raise is $450.
- Issuance exempt from registration under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001493152-25-008395
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315225008395/0001493152-25-008395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315225008395/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008395
- JSON: https://secwatch.observer/filing/0001493152-25-008395.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008395.txt

## Key facts
- Governance Changes
  Ocean Biomedical, Inc.: Filed amendment to Certificate of Incorporation to create a series of preferred stock via Certificate of Designation (effective 2025-02-20).
  - Change: charter amendment
  - Effective: 2025-02-20
  source text: On February 20, 2025, Ocean Biomedical, Inc. filed an amendment to its Certificate of Incorporation to create a series of preferred stock pursuant to a Certificate of Designation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315225008395/0001493152-25-008395-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.